BEAM FY 2025 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$140M+120.0% YoY

Gross Profit

$117M84.0% margin

Operating Income

-$384M-274.6% margin

Net Income

-$80M-57.2% margin

EPS (Diluted)

$-0.81

Cash Flow

Operating Cash Flow

-$345M

Free Cash Flow

-$360M

Stock-Based Comp.

$94M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$243M

Stockholders' Equity

$1.2B

Cash & Equivalents

$295M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$140M	$64M	+120.0%
Gross Profit	$117M	-$304M	+138.6%
Operating Income	-$384M	-$416M	+7.7%
Net Income	-$80M	-$377M	+78.8%